Swiss Leaders Seek Roche, Novartis Talks Amid US Tariffs

The Swiss government has initiated talks with Roche Holding AG and Novartis AG, two major pharmaceutical companies based in Switzerland, to address the impact of US tariffs. Switzerland has faced the highest US tariffs among developed countries, prompting the government's outreach to these prominent Swiss firms. The discussions aim to understand the challenges posed by the tariff situation and explore potential solutions or mitigating measures. As Switzerland's largest companies, Roche and Novartis play a significant role in the country's economy and are likely to be affected by the increased tariffs imposed by the United States. The Swiss government's proactive approach in engaging with these pharmaceutical giants suggests its efforts to support local industries and maintain the country's economic resilience in the face of the tariff-related challenges. The outcome of these talks could have implications for the broader Swiss-US trade relationship and the competitiveness of the Swiss pharmaceutical sector.